NCT04032353Unknown不适用
Medical Consortium for Screening Upper Gastrointestinal Cancers With Magnetically Controlled Capsule Gastroscopy
Yanqing Li1 个研究点 分布在 1 个国家目标入组 10,000 人开始时间: 2018年12月31日最近更新:
适应症
干预措施
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 10,000
- 试验地点
- 1
- 主要终点
- the incidence of upper gastrointestinal cancers, including gastric cancer and esophageal cancer.
研究概览
简要总结
The aim of our study was to demonstrate the efficacy and feasibility of the medical consortium for screening upper gastrointestinal cancers with magnetically controlled capsule gastroscopy.
详细描述
In this study, the investigators designed a propective cohort study to evaluate the the efficacy and feasibility of medical consortium for screening upper gastrointestinal cancers (MCSC) with magnetically controlled capsule gastroscopy (MCCG).
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Screening
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 80 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •asymptomatic subjects undergong magnetically controlled capsule gastroscopy for health checkup in medical consotium;
- •subjects able to give informed consent
排除标准
- •suspected or known intestinal stenosis, obstruction, or fistula;
- •inoperability of refusal to accept any abdominal surgery;
- •dysphagia or gastric paralysis;
- •previous history of gastrointestinal disease;
- •with pacemaker, implanted-cardiac defibrillator or other implanted electromedical devices;
- •need for standard magnetic resonance imaging examination within seven days after swallowing the MCCG, unless the capsule is confirmed to have been excreted;
- •other factors that are not suitable for inclusion evaluated by medical stuff
研究组 & 干预措施
Medical Consortium
Other
subjects involved in medical consortium for screening upper gastrointestinal canccers(MCSC)
干预措施: Medical Consortium (Other)
结局指标
主要结局
the incidence of upper gastrointestinal cancers, including gastric cancer and esophageal cancer.
时间窗: 12 months
次要结局
- tthe focal lesions of upper gastrointestinal tract(12 months)
研究者
Yanqing Li
vice president of Qilu Hospital
Shandong University
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Screening for Stomach Diseases and Colorectal Neoplasms With the Fecal TestingStomach DiseaseColorectal CancerNCT01741363National Taiwan University Hospital99,314
已完成
不适用
Study of EndoBarrier Liner for Treatment of Type 2 Diabetes StudyType 2 DiabetesNCT00986349Morphic Medical Inc.23
已完成
不适用
Multicenter Study of Patient-reported Gastrointestinal Symptoms in People With Cystic FibrosisCystic FibrosisNCT03801993Chris Goss402
已完成
不适用
Clinical Utility Evidence for TissueCypher®Gastro-Intestinal DisorderBarrett EsophagusNCT05200325Qure Healthcare, LLC280
已完成
不适用
Evaluation of Potential Screening Tools for Metabolic Body Odor and HalitosisNutritional and Metabolic DiseasesNCT02692495Mebo Research, Inc.16